EX-27 2 y42478ex27.txt FINANCIAL DATA SCHEDULE
9 THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CURRENT REPORT ON FORM 10-Q FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS AND DISCLOSURES. 1,000,000 9-MOS DEC-31-2000 JAN-01-2000 SEP-30-2000 881 5,156 43,788 140,428 5,050 0 0 26,987 258 281,681 40,184 108,204 99,854 21,477 0 694 502 10,766 281,681 1,447 447 7,735 9,629 1,614 8,447 1,182 (11) 284 5,124 2,513 1,684 0 0 1,684 9.64 9.05 .85 128 64 0 0 406 (24) 12 392 8 69 315 Includes securities purchased under agreements to resell and / or federal funds sold. Includes securities sold under agreements to repurchase and federal funds purchased, commercial paper, and other liabilities for borrowed money. Includes trading account liabilities, accounts payable and accrued expenses, other liabilities, and company-obligated mandatorily redeemable preferred securities of subsidiaries. Includes gain and losses on debt and equity investment securities, other-than-temporary impairments or write-downs in value, and related dividend income. Includes employee compensation and benefits, net occupancy, technology and communications, and other expenses. Amounts relate to the firm's allowance for loan losses and allowance for credit losses on lending commitments, such as commitments, standby letter of credit, and guarantees. The unallocated allowance represents the expected loss components of our allowances for credit losses. The allocated amounts represent our allowances to specific counterparties determined in accordance with SFAS No. 114 and SFAS No. 5, for loans and off-balance-sheet credit instruments, respectively.